| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
05-29-2020, 06:41 PM
|
#2 | |||
|
||||
|
Senior Member
|
I haven't tried either of these drugs but Tecfidera is less likely to cause liver damage according to these studies:
Plegridy is one of the interferons, and so this information applies to it--from a study done at the National Institute of Diabetes and Digestive and Kidney Diseases a couple of years back: Beta Interferon - LiverTox - NCBI Bookshelf The same overview found that Tecfidera has involved less liver damage--specifically: Quote:
However, there have been a few PML cases in patients taking Tecfidera. I'm sorry I don't have any information on Plegridy and PML. You might want to weigh the risks of one drug against the risks of the other.
__________________
Repeal the law of gravity! MS diagnosed 1980. Type 2 diabetes, osteoarthritis, osteopenia. Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, 12/16/20 - 3/16/24 |
|||
|
 Reply With Quote
|
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Has anyone tried Plegridy? | Multiple Sclerosis | |||
| Tecfidera | Multiple Sclerosis | |||
| Tecfidera | New Member Introductions | |||
| Plegridy, new Beta-Interferon drug from Biogen | Multiple Sclerosis | |||
| Tecfidera & PML ??? | New Member Introductions | |||
Threaded Mode